About Samaria Behavioral Health Center
Services
Type of Care
Substance use treatment
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Outpatient; Outpatient methadone/buprenorphine or naltrexone treatment; Regular outpatient treatment
Opioid Medications used in Treatment
Buprenorphine used in Treatment; Naltrexone used in Treatment
Type of Alcohol Use Disorder Treatment
This facility administers/prescribes medication for alcohol use disorder
External Source of Medications Used for Alcohol Use Disorder Treatment
In-network prescribing entity
Type of Opioid Treatment
Buprenorphine maintenance; Prescribes buprenorphine; Prescribes naltrexone; Relapse prevention with naltrexone; Maintenance service with medically supervised withdrawal after stabilization
Pharmacotherapies
Acamprosate (Campral®); Disulfiram; Buprenorphine sub-dermal implant; Buprenorphine with naloxone; Buprenorphine without naloxone; Naltrexone (oral); Naltrexone (extended-release, injectable); Clonidine; Medication for mental disorders; Non-nicotine smoking/tobacco cessation
Treatment Approaches
Brief intervention; Cognitive behavioral therapy; Motivational interviewing; Relapse prevention; Substance use disorder counseling; Telemedicine/telehealth therapy
Facility Operation (e.g., Private, Public)
Private for-profit organization
License/Certification/Accreditation
State department of health; Drug Enforcement Agency (DEA)
Payment/Insurance/Funding Accepted
Medicare; Medicaid; Private health insurance; Cash or self-payment; State-financed health insurance plan other than Medicaid
Special Programs/Groups Offered
Adolescents; Young adults; Adult women; Pregnant/postpartum women; Adult men; Lesbian, gay, bisexual, transgender, or queer/questioning (LGBTQ); Veterans; Clients with co-occurring mental and substance use disorders; Clients with co-occurring pain and substance use disorders; Clients who have experienced sexual abuse; Clients who have experienced intimate partner violence, domestic violence; Clients who have experienced trauma
Assessment/Pre-treatment
Comprehensive mental health assessment; Comprehensive substance use assessment; Complete medical history/physical exam; Screening for tobacco use; Screening for substance use; Screening for mental disorders
Testing
Breathalyzer or blood alcohol testing; Drug or alcohol urine screening
Transitional Services
Aftercare/continuing care; Naloxone and overdose education; Outcome follow-up after discharge
Other Services
Treatment for other addiction disorder
Education and Counseling Services
Substance use disorder education; Smoking/vaping/tobacco cessation counseling
Facility Smoking Policy
Smoking not permitted
Age Groups Accepted
Children/Adolescents; Adults
Gender Accepted
Female; Male
Language Services
Other languages (excluding Spanish)
Other Languages
Creole; French
Facility Vaping Policy
Vaping not permitted
Ancillary Services
Mental health services; Integrated primary care services; Suicide prevention services
Type of Care
Substance use treatment
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Outpatient; Outpatient methadone/buprenorphine or naltrexone treatment; Regular outpatient treatment
Opioid Medications used in Treatment
Buprenorphine used in Treatment; Naltrexone used in Treatment
Type of Alcohol Use Disorder Treatment
This facility administers/prescribes medication for alcohol use disorder
External Source of Medications Used for Alcohol Use Disorder Treatment
In-network prescribing entity
Type of Opioid Treatment
Buprenorphine maintenance; Prescribes buprenorphine; Prescribes naltrexone; Relapse prevention with naltrexone; Maintenance service with medically supervised withdrawal after stabilization
Pharmacotherapies
Acamprosate (Campral®); Disulfiram; Buprenorphine sub-dermal implant; Buprenorphine with naloxone; Buprenorphine without naloxone; Naltrexone (oral); Naltrexone (extended-release, injectable); Clonidine; Medication for mental disorders; Non-nicotine smoking/tobacco cessation
Treatment Approaches
Brief intervention; Cognitive behavioral therapy; Motivational interviewing; Relapse prevention; Substance use disorder counseling; Telemedicine/telehealth therapy
Facility Operation (e.g., Private, Public)
Private for-profit organization
License/Certification/Accreditation
State department of health; Drug Enforcement Agency (DEA)
Payment/Insurance/Funding Accepted
Medicare; Medicaid; Private health insurance; Cash or self-payment; State-financed health insurance plan other than Medicaid
Special Programs/Groups Offered
Adolescents; Young adults; Adult women; Pregnant/postpartum women; Adult men; Lesbian, gay, bisexual, transgender, or queer/questioning (LGBTQ); Veterans; Clients with co-occurring mental and substance use disorders; Clients with co-occurring pain and substance use disorders; Clients who have experienced sexual abuse; Clients who have experienced intimate partner violence, domestic violence; Clients who have experienced trauma
Assessment/Pre-treatment
Comprehensive mental health assessment; Comprehensive substance use assessment; Complete medical history/physical exam; Screening for tobacco use; Screening for substance use; Screening for mental disorders
Testing
Breathalyzer or blood alcohol testing; Drug or alcohol urine screening
Transitional Services
Aftercare/continuing care; Naloxone and overdose education; Outcome follow-up after discharge
Other Services
Treatment for other addiction disorder
Education and Counseling Services
Substance use disorder education; Smoking/vaping/tobacco cessation counseling
Facility Smoking Policy
Smoking not permitted
Age Groups Accepted
Children/Adolescents; Adults
Gender Accepted
Female; Male
Language Services
Other languages (excluding Spanish)
Other Languages
Creole; French
Facility Vaping Policy
Vaping not permitted
Ancillary Services
Mental health services; Integrated primary care services; Suicide prevention services
